Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00014248 · ClinicalTrials.gov registry record · Phase 1
Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors
A Phase 1 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00014248 is a Phase 1 study that has completed, run by Dartmouth-Hitchcock Medical Center.
The verdict
NCT00014248, a Phase 1 study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Adenosine triphosphate may decrease weight loss and improve muscle strength in patients with advanced solid tumors. PURPOSE: Phase I trial to study the effectiveness of adenosine triphosphate in controlling loss of weight and loss of muscle mass in patients who have advanced solid tumors.
Interventions
- PROCEDURE quality-of-life assessment
- DRUG adenosine triphosphate
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00014248
The ClinicalTrials.gov registry entry for NCT00014248 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which quality-of-life assessment is the first listed.
NCT00014248 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00014248 about?
NCT00014248 is a clinical study titled "Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors". RATIONALE: Adenosine triphosphate may decrease weight loss and improve muscle strength in patients with advanced solid tumors. PURPOSE: Phase I trial to study the effectiveness of adenosine triphosphate in controlling loss of weight and loss of muscle mass in patients who have advanced solid tumors...
What is the current status of trial NCT00014248?
This trial is currently completed. It is a Phase 1 study. The study started on 2000-10.
What interventions are being tested in trial NCT00014248?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), adenosine triphosphate (DRUG).
Who is sponsoring clinical trial NCT00014248?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.